Intradermal ChAdOx1 Vaccine Following Two CoronaVac Shots: A Case Report

Inactivated SARS-CoV-2 vaccines are used in many countries with uncertain immunogenicity. Intradermal ChAdOx1 has been proposed as a resource-efficient heterologous third booster shot. A 52-year-old healthy male healthcare professional had received two intramuscular CoronaVac shots on 21 April and 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Singhatiraj, Ekachai, Pongpirul, Krit, Jongkaewwattana, Anan, Hirankarn, Nattiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472992/
https://www.ncbi.nlm.nih.gov/pubmed/34579227
http://dx.doi.org/10.3390/vaccines9090990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472992/
https://www.ncbi.nlm.nih.gov/pubmed/34579227
http://dx.doi.org/10.3390/vaccines9090990

Ejemplares similares